|
FY2026
12 months to Mar 28, 2026
|
FY2025
12 months to Mar 29, 2025
|
FY2024
12 months to Mar 30, 2024
|
FY2023
12 months to Mar 25, 2023
|
FY2022
12 months to Mar 26, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Intangibles impairment | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense) | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Basic earnings per share (in dollars per share) | |||||
| Diluted earnings per share (in dollars per share) | |||||
| Basic weighted average common shares outstanding (in shares) | |||||
| Diluted weighted average common shares outstanding (in shares) |
Loading...
